Search results
UCLH Cancer Academy
Supplier
Cardiac Toxicity of Cancer Chemotherapy
Author(s):
Aarti Asnani
Start date:
Aug 08, 2017
Broadcast
Heart Failure and Cancer
Author(s):
Alessandra Cuomo
,
Alessio Rodolico
,
Amalia Galdieri
,
et al
Added:
3 years ago
Article
Author(s):
Carine E Hamo
,
Michelle W Bloom
Added:
3 years ago
Heart disease and cancer are the two leading causes of death, together accounting for almost 50 % of deaths in the US.1 Unfortunately, the tremendous success in improving cancer survival is often attenuated by downstream cardiovascular complications from cancer therapy. Acute cardiac toxicity may limit the ability to use life-saving cancer therapy and chronic toxicity limits overall survival. As…
View more
Author(s):
Mark Sweeney
,
Angela Yiu
,
Alexander Lyon
Added:
3 years ago
Cancer and the anti-cancer treatments prescribed by oncologists have long been known to have significant effects on muscle, causing a catabolic muscle wasting state and resulting in widespread and progressive atrophy of most muscle groups.1 This process contributes significantly to the cancer cachexia seen in up to 80% of all patients with cancer, resulting in progressive weight loss, loss of…
View more
Author(s):
Arjun K Ghosh
,
Deepak L Bhatt
,
Cezar Iliescu
Added:
2 years ago
Cardio-oncology topic editor, Dr Arjun Ghosh (University College London Hospital and Hatter Cardiovascular Institute, UK) is joined by Dr. Deepak L. Bhatt (Brigham and Women's Hospital, Medical School, US) and Dr Cezar Iliescu(The University of Texas MD Anderson Cancer Center, US) to discuss interventional issues in cancer patients with a focus on patients with acute coronary syndromes (ACS)…
View more
Author(s):
Marielle Scherrer-Crosbie
Added:
1 year ago
ACC.23/WCC — In this succinct late-breaking science interview, Investigator, Dr Marielle Scherrer-Crosbie (Hospital of the University of Pennsylvania, US) discusses the results from the STOP-CA trial (Massachusetts General Hospital). This randomized phase II trial aims to investigate whether atorvastatin, a commonly prescribed statin drug for reducing cholesterol levels, can protect the heart…
View more
Author(s):
Edoardo Bertero
,
Pietro Ameri
,
Christoph Maack
Added:
3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular…
View more
Randall A. Oyer
Research Area(s) / Expertise:
Job title: Medical Director, Ann B. Barhshinger Cancer Institute, Lancaster General Hospital, University of Pennsylvania, US
Author
Anecita P. Fadol
Research Area(s) / Expertise:
Job title: Department of Nursing, Division of SrVP and Chief Nursing Officer
Author